“…Based on crystal structures of sulfotransferases engaged with oligosaccharide substrates, some of these enzymes have been engineered via site-directed mutagenesis to alter their specificities to improve control of the chemoenzymatic pathway (Liu et al, 2014;Liu et al, 2012;Xu et al, 2008;Xu et al, 2017b;Yi et al, 2020). Particularly, a triple mutation of zf6-OST-3 designed based on the crystal structures, allows for sulfation only on the non-reducing terminal glucosamine, providing fine-tuned control of 6-O-sulfation in the chemoenzymatic synthesis pathway (Yi et al, 2020). Cytosolic sulfotransferases are also being investigated for their ability to generate sulfated products for biological reagents and drug discovery (Lamb et al, 2006;Matsumura et al, 2018;Shi et al, 2012;Shimohira et al, 2017;Xie et al, 2020).…”